ArticleThe journal of allergy and clinical immunology. In practice2022

A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter.

Yohei Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.